Apolipoprotein E genotype affects plasma lipid response to atorvastatin in a gender specific manner. [electronic resource]
Producer: 20011025Description: 183-93 p. digitalISSN:- 0021-9150
- Anticholesteremic Agents -- therapeutic use
- Apolipoproteins E -- genetics
- Atorvastatin
- Double-Blind Method
- Female
- Genotype
- Heptanoic Acids -- therapeutic use
- Heterozygote
- Homozygote
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- therapeutic use
- Hypercholesterolemia -- blood
- Lipids -- blood
- Lipoproteins -- blood
- Lovastatin -- therapeutic use
- Male
- Middle Aged
- Pyrroles -- therapeutic use
- Sex Factors
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.